Skip to content

Efficacy of intra-articular injection of a newly developed plasma rich in growth factors (PRGF) versus hyaluronic acid on pain and function of patients with knee osteoarthritis

Efficacy of intra-articular injection of a newly developed plasma rich in growth factors (PRGF) versus hyaluronic acid on pain and function of patients with knee osteoarthritis: A single-blinded randomized clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20130523013442N23
Enrollment
60
Registered
2018-03-24
Start date
2018-02-19
Completion date
Unknown
Last updated
2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis. Osteoarthritis of knee

Interventions

Intervention 1: Intervention group 1: plasma rich in growth factor, knee intraarticular injection, 4 to 6 milliliter, 2 times, 3 weeks interval. Intervention 2: Intervention group 2 : Hyaluronic acid

Sponsors

Vice chancellor for research, Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 75 Years

Inclusion criteria

Inclusion criteria: Age between 45-75 years Symptomatic knee OA with the pain aggravated by weight bearing Symptoms lasting for at least 6 months despite conservative treatment Kellgren-Lawrance radiology scoring system scores ranging from 2-3

Exclusion criteria

Exclusion criteria: History of trauma , surgery or any invasive procedure in the affected joint during the past 6 months Mal-alignment in lower limbs and abnormal blood count or impared coagulation test Pregnant women Patients who were under immunosuppressant treatments Those with an underlying systemic arthropathy (secondary OA) Patients been treated with angiotensin converting enzyme inhibitors (ACE I) and significant deficiency in glucose 6 - phosphate dehydrogenase (G6PD) level

Design outcomes

Primary

MeasureTime frame
Knee Pain. Timepoint: Before intervention, 6 months & 12months after intervention. Method of measurement: Change of WOMAC questionnaire scores.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactPegah Yavari

Physical Medicine and Rehabilitation Department, Shahid Beheshti University of Medical Sciences, Sch

yavari@sbmu.ac.ir+98 21 2200 8941

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026